4.6 Review

TDP-43 and FUS: a nuclear affair

Journal

TRENDS IN NEUROSCIENCES
Volume 34, Issue 7, Pages 339-348

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tins.2011.05.002

Keywords

-

Categories

Funding

  1. Center for Integrated Protein Science Munich (CIPSM)
  2. Competence Network of Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung (BMBF)
  3. Sonderforschungsbereich Molecular Mechanisms of Neurodegeneration [SFB 596]
  4. EMBO
  5. Ludwig-Maximilians University

Ask authors/readers for more resources

Misfolded TAR DNA binding protein 43 (TDP-43) and Fused-In-Sarcoma (FUS) protein have recently been identified as pathological hallmarks of the neurodegenerative disorders amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) characterized by the presence of ubiquitin-positive inclusions (FTLD-U). Although TDP-43 and FUS are normally located predominantly in the nucleus, pathological TDP-43 and FUS inclusions are mostly found in the cytosol. Cytosolic deposition is paralleled by a striking nuclear depletion of either protein. Based on a number of recent findings, we postulate that defects in nuclear import are an important step towards TDP-43 and FUS dysfunction. Failure of nuclear transport can arise from mutations within a nuclear localization signal or from age-related decline of nuclear import mechanisms. We propose that nuclear import defects in combination with additional hits, for example cellular stress and genetic risk factors, may be a central underlying cause of ALS and FTLD-U pathology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available